Evidence map›Paper›PMID 38905326›Full record

ArticleScience immunology2024

SARS-CoV-2 inflammation durably imprints memory CD4 T cells.

Sophie L Gray-Gaillard, Sabrina M Solis, Han M Chen, Clarice Monteiro, Grace Ciabattoni, Marie I Samanovic, Amber R Cornelius, Tijaana Williams, Emilie Geesey, Miguel Rodriguez and 5 more

Erratum issuedAbstract read
In one paragraph

Article in Science immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Cytotoxic CD4Signal transduction and targeted therapy · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Cytotoxic T Cells: Kill, Memorize, and Mask to Maintain Immune Homeostasis.International journal of molecular sciences · 2025
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Sophie L Gray-GaillardDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0002-4884-5956
Sabrina M SolisDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0003-1653-1570
Han M ChenDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0009-0001-8124-5792
Clarice MonteiroDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0001-9910-0594
Grace CiabattoniDepartment of Microbiology, New York University School of Medicine, New York, NY, USA.
Marie I SamanovicDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0002-6987-2232
Amber R CorneliusDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.
Tijaana WilliamsDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0009-0004-7337-8116
Emilie GeeseyDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0009-0009-8753-6118
Miguel RodriguezDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.
Mila Brum OrtigozaDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0002-9428-1469
Ellie N IvanovaDepartment of Pathology, New York University School of Medicine, New York, NY, USA.ORCID 0000-0002-1850-9505
Sergei B KoralovDepartment of Pathology, New York University School of Medicine, New York, NY, USA.ORCID 0000-0002-4843-3791
Mark J MulliganDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0001-7262-9746
Ramin Sedaghat HeratiDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0003-2613-4050

Funding

Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MARK Reid PHILIPS · 1985 to 2026
$83.1M
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00014 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2021 to 2025
$62.6M
Virology CoreU19AI082630 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI GEORG Michael LAUER · 2009 to 2026
$48.1M
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU) - DMID 21-0012UM1AI148574 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Angelica Cifuentes Kottkamp, Anoma Nellore · 2020 to 2026
$23.9M
A systems immunology approach for predicting poor responses to Hepatitis B vaccinationR01AI158617 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HERATI, RAMIN · 2021 to 2025
$3.9M
Microbial triggers and molecular mechanisms of Th17 mediated airway inflammation-Resubmission-1R01HL125816 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KORALOV, SERGEI BORISOVICH · 2015 to 2019
$3.3M
Biology of Influenza Virus TransmissionK08AI141759 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ORTIGOZA, MILA BRUM · 2019 to 2023
$939k
Delineating The Differences Between Short-Lived And Long-Lived Plasma CellsR21AI137752 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KORALOV, SERGEI BORISOVICH · 2019 to 2020
$466k
Non-coding RNAs in B lymphocyte development and functionR21AI110830 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KORALOV, SERGEI BORISOVICH · 2014 to 2014
$170k
NCATS NIH HHS UL1 TR001445NCI NIH HHS P30 CA016087NHLBI NIH HHS R01 HL125816NIAID NIH HHS 75N93021C00014NIAID NIH HHS K08 AI141759NIAID NIH HHS R01 AI158617NIAID NIH HHS R21 AI110830NIAID NIH HHS R21 AI137752NIAID NIH HHS U19 AI082630NIAID NIH HHS UM1 AI148574
6 · The paper itself

Abstract

Memory CD4 T cells are critical to human immunity, yet it is unclear whether viral inflammation during memory formation has long-term consequences. Here, we compared transcriptional and epigenetic landscapes of Spike (S)-specific memory CD4 T cells in 24 individuals whose first exposure to S was via SARS-CoV-2 infection or mRNA vaccination. Nearly 2 years after memory formation, S-specific CD4 T cells established by infection remained enriched for transcripts related to cytotoxicity and for interferon-stimulated genes, likely because of a chromatin accessibility landscape altered by inflammation. Moreover, S-specific CD4 T cells primed by infection had reduced proliferative capacity in vitro relative to vaccine-primed cells. Furthermore, the transcriptional state of S-specific memory CD4 T cells was minimally altered by booster immunization and/or breakthrough infection. Thus, infection-associated inflammation durably imprints CD4 T cell memory, which affects the function of these cells and may have consequences for long-term immunity.

Indexed as

CD4-Positive T-LymphocytesCOVID-19Immunologic MemoryInflammationMemory T CellsSARS-CoV-2AdultCOVID-19 VaccinesFemaleHumansMaleSpike Glycoprotein, CoronavirusCOVID-19 VaccinesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID38905326
PMCPMC11824880

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.